Ontario Teachers Pension Plan Board Buys 38,505 Shares of Progyny, Inc. (NASDAQ:PGNY)

Ontario Teachers Pension Plan Board boosted its position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 346.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 49,627 shares of the company's stock after purchasing an additional 38,505 shares during the quarter. Ontario Teachers Pension Plan Board owned about 0.06% of Progyny worth $856,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Barclays PLC boosted its position in shares of Progyny by 95.7% during the fourth quarter. Barclays PLC now owns 1,382,205 shares of the company's stock worth $23,843,000 after acquiring an additional 676,048 shares during the last quarter. Rockefeller Capital Management L.P. grew its stake in Progyny by 26.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 797,894 shares of the company's stock valued at $13,778,000 after purchasing an additional 164,693 shares during the last quarter. Quinn Opportunity Partners LLC acquired a new position in Progyny in the 4th quarter worth approximately $345,000. Covestor Ltd increased its stake in shares of Progyny by 69.4% in the fourth quarter. Covestor Ltd now owns 6,868 shares of the company's stock worth $118,000 after acquiring an additional 2,814 shares during the period. Finally, Capital Fund Management S.A. raised its stake in shares of Progyny by 147.3% during the 4th quarter. Capital Fund Management S.A. now owns 199,136 shares of the company's stock valued at $3,435,000 after buying an additional 118,604 shares during the last quarter. 94.93% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on PGNY. Bank of America increased their target price on shares of Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. BTIG Research upgraded shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price on the stock in a report on Monday, March 31st. JPMorgan Chase & Co. boosted their price objective on Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a report on Tuesday, January 28th. Finally, Canaccord Genuity Group raised their price objective on shares of Progyny from $17.00 to $23.00 and gave the company a "hold" rating in a report on Friday, February 28th. Eight research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $23.64.

Progyny Stock Up 1.4 %

PGNY stock traded up $0.29 during trading hours on Tuesday, hitting $21.66. The company's stock had a trading volume of 108,153 shares, compared to its average volume of 1,734,229. The company has a market capitalization of $1.86 billion, a PE ratio of 37.40, a price-to-earnings-growth ratio of 2.39 and a beta of 1.33. The stock has a 50 day moving average price of $21.93 and a two-hundred day moving average price of $18.92. Progyny, Inc. has a 12 month low of $13.39 and a 12 month high of $33.84.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.